SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000946644-05-000015
Filing Date
2005-10-28
Accepted
2005-10-28 17:00:24
Documents
6
Period of Report
2005-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 r8k_1025.txt 8-K/A 4305
2 rexh_101.txt EX-99.13 OTH CONTRCT 17160
3 rexh_102.txt EX-99.13 OTH CONTRCT 174657
4 rexh_103.txt EX-99.13 OTH CONTRCT 188817
5 rexh_104.txt EX-99.13 OTH CONTRCT 195426
6 rexh_105.txt EX-99.13 OTH CONTRCT 72069
  Complete submission text file 0000946644-05-000015.txt   654025
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-13441 | Film No.: 051163997
SIC: 2836 Biological Products, (No Diagnostic Substances)